All In Biotech

Drug Trial Radar · NCT00907296

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

A Multi-center, Randomized, Double Blind, Placebo-controlled Study of AMG 785 in Skeletally Mature Adults With a Fresh Unilateral Tibial Diaphyseal Fracture Status Post Definitive Fracture Fixation With an Intramedullary Nail

Last checked: Nov 20, 2026Latest source record: Sep 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 402 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

402

Actual

Start

Sep 2, 2009

Primary completion

Mar 6, 2012

Study completion May 10, 2013

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
Collaborators
UCB Pharma
First posted
May 22, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to investigate the effect of romosozumab compared with placebo on time to radiographic healing of fresh tibial diaphyseal fractures (fractures in the midsection of the shinbone).

Conditions

  • Fracture Healing

Interventions

  • RomosozumabBiological

    Administered by subcutaneous injection

  • PlaceboDrug

    Administered by subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Radiographic HealingTime frame: 52 weeks

Locations

103 sites in 23 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama

  • Research Site

    Orange, California

  • Research Site

    Aurora, Colorado

  • Research Site

    Denver, Colorado

  • Research Site

    Jacksonville, Florida

  • Research Site

    Indianapolis, Indiana

  • Research Site

    Detroit, Michigan

  • Research Site

    St Louis, Missouri

  • Research Site

    Brooklyn, New York

  • Research Site

    Rochester, New York

  • Research Site

    Altoona, Pennsylvania

  • Research Site

    Philadelphia, Pennsylvania

  • Research Site

    Columbia, South Carolina

  • Research Site

    Sandy City, Utah

  • Research Site

    Geelong, Victoria, Australia

  • Research Site

    Parkville, Victoria, Australia

  • Research Site

    Blagoevgrad, Bulgaria

  • Research Site

    Pleven, Bulgaria

  • Research Site

    Plovdiv, Bulgaria

  • Research Site

    Rousse, Bulgaria

  • Research Site

    Sofia, Bulgaria

  • Research Site

    Red Deer, Alberta, Canada

  • Research Site

    Ajax, Ontario, Canada

  • Research Site

    Thunder Bay, Ontario, Canada

  • Research Site

    Toronto, Ontario, Canada

  • Research Site

    Waterloo, Ontario, Canada

  • Research Site

    Windsor, Ontario, Canada

  • Research Site

    Montreal, Quebec, Canada

  • Research Site

    Montreal, Quebec, Canada

  • Research Site

    Ã…rhus C, Denmark

  • Research Site

    Hvidovre, Denmark

  • Research Site

    København NV, Denmark

  • Research Site

    Tallinn, Estonia

  • Research Site

    Tartu, Estonia

  • Research Site

    Lille, France

  • Research Site

    Marseille, France

  • Research Site

    Nantes, France

  • Research Site

    Paris, France

  • Research Site

    Aachen, Germany

  • Research Site

    Hamburg, Germany

Showing 40 of 103 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.